Key facts
- This page summarizes Timothy Wright's Form 4 filing for AGENUS INC (AGEN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Jun 2025, 16:10.
Timothy Wright - 17 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)
- Reporting relationship
- Director
- Issuer ticker
- AGEN
- Reported as of
- 17 Jun 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Jun 2025, 16:10:06 UTC
- Prior SEC filing
- 02 Apr 2025
- Next SEC filing
- 03 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/Christine Klaskin, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy Wright filed Form 4 for AGENUS INC (AGEN) on 20 Jun 2025.
Change
- Previous filing in this sequence was filed on 02 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001383313
Primary reporting owner
Wright Timothy
- Relationship
- Director
- Address
- C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
- Signature
- /s/Christine Klaskin, as Attorney-in-Fact
- Signature date
- 20 Jun 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGEN
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +750
- Change %
- Price
- $0.000000
- Shares after
- 750
- Date
- 17 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 750
- Exercise price
- $3.02
- Footnotes
- F1
AGEN
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +15,000
- Change %
- Price
- $0.000000
- Shares after
- 15,000
- Date
- 17 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $3.02
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on May 28, 2026, and the balance vesting in equal quarterly installments thereafter.
Footnote F2
Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.